BIT
SCLN

BlackRock Institutional Trust’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

BlackRock Institutional Trust’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$17.3M Sell
1,604,543
-8,522
-0.5% -$85.2K ﹤0.01% 2069
2016
Q3 		$16.5M Buy
1,613,065
+10,086
+0.6% +$110K ﹤0.01% 2014
2016
Q2 		$20.9M Sell
1,602,979
-275,261
-15% -$3.61M ﹤0.01% 1819
2016
Q1 		$20.7M Sell
1,878,240
-221,519
-11% -$1.97M ﹤0.01% 1812
2015
Q4 		$19.3M Sell
2,099,759
-49,193
-2% -$412K ﹤0.01% 1886
2015
Q3 		$14.9M Sell
2,148,952
-109,851
-5% -$941K ﹤0.01% 2033
2015
Q2 		$22.2M Buy
2,258,803
+193,919
+9% +$1.77M ﹤0.01% 1853
2015
Q1 		$18.3M Buy
2,064,884
+16,291
+0.8% +$130K ﹤0.01% 1998
2014
Q4 		$17.9M Sell
2,048,593
-127,076
-6% -$1.03M ﹤0.01% 1980
2014
Q3 		$15M Sell
2,175,669
-120,675
-5% -$723K ﹤0.01% 2062
2014
Q2 		$12.1M Sell
2,296,344
-308,645
-12% -$1.5M ﹤0.01% 2313
2014
Q1 		$11.9M Sell
2,604,989
-364,712
-12% -$1.76M ﹤0.01% 2316
2013
Q4 		$15M Buy
2,969,701
+283,288
+11% +$1.36M ﹤0.01% 2145
2013
Q3 		$13.6M Sell
2,686,413
-178,698
-6% -$995K ﹤0.01% 2135
2013
Q2 		$14.2M Buy
+2,865,111
New +$13.6M ﹤0.01% 2065

Other funds holding SCLN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock Institutional Trust's SCLN Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Sciclone Pharmaceuticals Inc (SCLN) stake by 0.53% in Q4 2016, selling an estimated $85.2K and leaving 1,604,543 shares worth $17.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2069.

BlackRock Institutional Trust first reported a position in SCLN in Q2 2013 and has held it in 15 quarters since. The position peaked at $22.2M in Q2 2015. 153 funds tracked by Wall St. Rank hold SCLN as of Q4 2016.

  • BlackRock Institutional Trust held 1,604,543 shares of Sciclone Pharmaceuticals Inc worth $17.3M as of Q4 2016.
  • BlackRock Institutional Trust sold 8,522 Sciclone Pharmaceuticals Inc shares in Q4 2016, an estimated $85.2K.
  • Sciclone Pharmaceuticals Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2069 holding.
  • BlackRock Institutional Trust first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Sciclone Pharmaceuticals Inc position peaked at $22.2M in Q2 2015.
  • 153 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.